A dose selection study evaluating the safety and immunogenicity of 2 different doses of a new TB vaccine, MVA85A, in healthy volunteers who have previously been vaccinated with BCG
Phase of Trial: Phase I
Latest Information Update: 03 Apr 2008
At a glance
- Drugs MVA 85A (Primary)
- Indications Tuberculosis
- Focus Adverse reactions
- 09 Jul 2007 New trial record.